InvestorsHub Logo
Followers 157
Posts 13346
Boards Moderated 0
Alias Born 04/30/2014

Re: None

Thursday, 11/26/2015 3:38:45 PM

Thursday, November 26, 2015 3:38:45 PM

Post# of 41498
1)AMDA Current Rev 2)Fair price target.

1)Per Q3, AMDA Q3(Sept Q) revenue is $4,835,000. USD.
Its nine(9) month revenue(1/1/15 to 9/30/15) is $14,358,000. USD.
Its 2015 revenue is $19,500,000. USD.

2)Fair price target:
AMDA market cap should be at= (Rev)*(20)= ($19.5ML)*(20)=$390.ML
or $3.0223 per share.(Its pps is now ONLY $0.1371 per share).

Calculation: ($390ML)/(o/s=129,039,249 shares)= $3.0223.

3) If gets FDA approval, AMDA pps will be higher, much higher than $3.0223 per share because its revenues will be increased exponentially.

AMDA is a great company with tons of potentials to grow.

AMDA stock is at super bargain price because its pps is now ONLY $0.1371 which is less than its fair price target of $3.0223 per share.

$$$$$$$$$$$ AMDA $$$$$$$$$$$$$


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News